• 1 Feb 2024

CatSci to Attend RNA Leaders Europe Congress

  • Events

CatSci Ltd will be attending the RNA Leaders Europe Congress conference on 13th – 14th March 2024. Hosted at the Congress Centre Basel, this event will bring together key stakeholders to examine the current and future challenges and opportunities of RNA therapeutics. Facilitating two days of learning and networking, the conference aims to forge collaborations that will bring new discoveries to market.  

Our Oligonucleotide Group Lead, Dr Aled Williams, and our Business Development Manager, Ali Albeckai, will be attending this two-day conference. They are excited to network with like-minded individuals and explore how CatSci’s in-depth expertise enables the synthesis of all classes of therapeutics oligos, including siRNA, ASO, Gapmers and sgRNA, as well as GalNAc ligands and other conjugates at up to a 30g scale.  

Our in-depth expertise in oligonucleotide R&D and manufacturing goes hand-in-hand with our GMP-analytical services, method development, and CMC expertise, including process optimisation studies for each unit operation in the oligonucleotide manufacturing process, as well as DoE optimisation and Quality by Design. 

If you would like to book a meeting with Aled and Ali at RNA Leaders, get in touch here.

Resources & Insights

  • 15 Jan 2026
  • Jordan Fletcher
Peptide Design in Contemporary DMTA Cycles: How DMTA Drives Translational Refinement
  • Design Make Test Analyse
  • DMTA
  • Peptides
  • Thought Leaders
  • 12 Jan 2026
  • Loïc Roux
Is Fragmented Discovery the Silent Saboteur of Complex Medicines?
  • Design-Make-Test
  • DMTA
  • Drug Discovery
  • Thought Leaders
  • 8 Dec 2025
  • Alison Gordon, Kathy Dodgson, Ryan Mordue, Tom Miller, Vesna Vetma O'Leary
PROductive TACtics Streamlined, multifaceted approaches to unlocking PROTAC® screening insights
  • Bioscience
  • Case Studies
489 KB
  • 2 Dec 2025
CatSci x BRAINBiocatalysts Conference 2026
  • Events